May 2026
1. LANIPEKUN OK, Wang Y, Miyamoto H
   Global vs. individual scoring when prostate needle cores from a single systematic biopsy site show Gleason score heterogeneity.
   Hum Pathol. 2026;171:106075.
   

   >> Share

   
   
2. WU DJ, Pacheco R, Chan E, Lowe AC, et al
   Prostatic adenocarcinoma identified on transurethral resection of bladder tumor: A clinicopathologic series of a diagnostically relevant potential pitfall.
   Hum Pathol. 2026;171:106059.
   

   >> Share

   
   April 2026
3. AYALA A, Ding Y, Bu P, Miles B, et al
   Prognostic value of nuclear versus cytoplasmic Cyclin D1 in human prostate cancer.
   Hum Pathol. 2026 Apr 27:106138. doi: 10.1016/j.humpath.2026.106138.
   

   >> Share

   
   March 2026
4. COLLINS K, Gupta S, Cheng L
   Updates in bladder and prostate pathology: Diagnostic consensus and clinical relevance.
   Hum Pathol. 2026;169:106018.
   

   >> Share

   
   February 2026
5. LANIPEKUN OK, Wang Y, Miyamoto H
   Clinical significance of the relative location of perineural cancer invasion on prostate biopsy: Detection within 1-mm of the core tip as an independent prognosticator.
   Hum Pathol. 2026;168:106015.
   

   >> Share

   
   January 2026
6. YU B, Zhou X, Bian F, Yan F, et al
   Long-term outcomes of prostate cancer patients with metastases in the anterior fat pad and pelvic lymph nodes: Nodal upstaging without worse long-term outcomes.
   Hum Pathol. 2026;170:106033.
   

   >> Share

   
   
7. WANG Y, Miyamoto H
   Quantitative assessment of cribriform intraductal carcinoma of the prostate is useful for risk stratification after radical prostatectomy.
   Hum Pathol. 2026;167:106008.
   

   >> Share

   
   
8. TEKIN B, Datta L, Zargham R, Sukov WR, et al
   Sarcomatoid carcinoma of the prostate - A single institution experience with emphasis on molecular genetic findings.
   Hum Pathol. 2026;167:105988.
   

   >> Share

   
   July 2025
9. WANG QY, Benzerdjeb N, Jaquet S, Stepanov A, et al
   Impact of hormone sensitivity status on aberrant expression of CK7, CK20, CDX2, GATA3 and TTF1 in prostate cancer.
   Hum Pathol. 2025;163:105877.
   

   >> Share

   
   June 2025
10. LIN R, Li H, Baraban E, Lotan T, et al
    Atypical intraductal proliferation (AIP) of the prostate: Findings in repeat biopsy or radical prostatectomy in patients who met pathologic criteria for active surveillance.
    Hum Pathol. 2025;160:105841.
    

    >> Share

    
    April 2024
11. WISSING M, Brimo F, McKercher G, Scarlata E, et al
    Long term evaluation of optimized Gleason grading in a large cohort of men with prostate cancer in Canada.
    Hum Pathol. 2024 Apr 10:S0046-8177(24)00054.
    

    >> Share

    
    February 2024
12. MAHLOW J, Barry M, Albertson DJ, Jo YJ, et al
    Histologic patterns in prostatic adenocarcinoma are not predictive of mutations in the homologous recombination repair pathway.
    Hum Pathol. 2024;144:28-33.
    

    >> Share

    
    January 2024
13. BACHERT SE, Di J, Zhang S, Short HE, et al
    TRPS1 expression in primary and metastatic prostatic adenocarcinoma, muscle invasive bladder urothelial carcinoma, and breast carcinoma: Is TRPS1 truly specific and sensitive for a breast primary?
    Hum Pathol. 2024;143:42-49.
    

    >> Share

    
    December 2023
14. DING Y, Bu P, Assylbekova B, Ruder S, et al
    Quantification of collagen content and stromal cellularity within reactive stroma is predictive of prostate cancer biochemical recurrence and specific death.
    Hum Pathol. 2023 Dec 28:S0046-8177(23)00258.
    

    >> Share

    
    
15. NWANZE J, Teramoto Y, Wang Y, Miyamoto H, et al
    Clinical impact of perineural invasion encircled completely vs. incompletely by prostate cancer on needle core biopsy.
    Hum Pathol. 2023;143:71-74.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share